| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |